A 26-Week Double-Blind, Randomized, Multicenter Parallel-Group Trial to Compare the Effects of Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women With Impaired Exercise Tolerance
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Atenolol; Valsartan
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms VALENCE
- 07 Nov 2011 Actual end date (August 2007) added as reported by ClinicalTrials.gov.
- 06 Jul 2007 Status changed from recruiting to completed.
- 17 Nov 2006 Status change